Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of Mozobil ± G-CSF for CD34+ stem cell mobilization in beta-thalassemia major
2009-014136-37Phase 2Completed
- Sponsor
- University of Washington
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of plerixafor in beta thalassemia (2 arms), sponsored by University of Washington. Primary endpoints: Safety of Mozobil or Mozobil + G-CSF mobilization and Clonogenic capacity of mobilized cells. Started Jun 2010; status: completed.
02
Drugs
plerixafor
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on 2009-014136-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014136-37.